NCT02911597View on ClinicalTrials.gov

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Depression
Interventions
DRUG

Naltrexone

adding naltrexone (or placebo) to a ketamine infusion to potentially block the effects of ketamine as an anti depressant.

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

Schatzberg, Alan, M.D.

INDIV

lead

Stanford University

OTHER

NCT02911597 - Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) | Biotech Hunter | Biotech Hunter